A nurse is preparing to administer 0800 medications to a client. The medication administration record (MAR) states "phenobarbital" and the medication the pharmacy supplied is pentobarbital. Which of the following actions should the nurse take?
Check the prescription in the client's medical record.
Ask the client if she has any allergies.
Ask the client what medication she took yesterday
Check the client's MAR to see what the client received the day before.
The Correct Answer is A
A. Checking the prescription in the client's medical record can help confirm the correct medication and dosage prescribed by the healthcare provider. It allows the nurse to verify the intended medication and compare it with what was supplied by the pharmacy.
B. While asking the client about allergies is important for medication safety, it may not directly address the discrepancy between the listed medication (phenobarbital) and the supplied medication (pentobarbital). Allergies are relevant to ensuring the safety of the medication administration, but they may not provide immediate clarification of the discrepancy.
C. This action may provide some context about the client's medication history, but it does not directly address the discrepancy between the listed medication and the supplied medication. The focus should be on confirming the correct medication for administration according to the client's current prescription.
D. This action may provide information about the client's previous medication administration history, but it does not directly address the discrepancy between the listed medication and the supplied medication. The nurse's primary concern should be to verify the correct medication to be administered at the current time.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. According to the recommended immunization schedule, the second dose of the MMR vaccine is typically administered at 4 to 6 years of age, before starting school. This booster dose helps ensure long- term immunity against measles, mumps, and rubella.
B. The MMR vaccine is typically administered in two doses: the first dose at 12 to 15 months of age and the second dose at 4 to 6 years of age. There is no need for additional MMR immunizations over the next 2 years if the child receives the recommended doses.
C. While the child may receive additional immunizations at 3 years of age, such as the hepatitis B vaccine, the second dose of the MMR vaccine is typically administered at 4 to 6 years of age, not 3 years.
D. Titer testing is typically not recommended for determining the need for further MMR immunizations in young children. The immunization schedule provides specific recommendations for MMR vaccine doses based on age, rather than individual titers.
Correct Answer is D
Explanation
D. The INR is the standard laboratory test used to monitor the effectiveness of warfarin therapy. Warfarin interferes with the synthesis of vitamin K-dependent clotting factors, primarily factors II, VII, IX, and X. The INR provides a standardized measure of coagulation status, allowing healthcare providers to adjust warfarin dosage to maintain therapeutic anticoagulation while minimizing the risk of bleeding or thrombosis.
A. Platelets are involved in the process of blood clotting, but checking platelet levels is not specific to monitoring warfarin therapy. Platelet count may be relevant in assessing overall coagulation status, but it is not the primary laboratory value monitored for warfarin therapy.
B. OPTT measures the time it takes for blood to clot after specific clotting factors are activated. While OPTT is used to monitor the effectiveness of heparin therapy, it is not routinely monitored for warfarin therapy. Warfarin primarily affects the extrinsic pathway of the coagulation cascade, and the international normalized ratio (INR) is the standard laboratory test used to monitor warfarin therapy.
C. White blood cell count assesses the number of white blood cells in the blood and is used to evaluate the immune system and detect infections. Monitoring white blood cell count is not specific to warfarin therapy and is not routinely checked prior to administering warfarin.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.